Rocket Pharmaceuticals Warrant
RCKTW
11 hedge funds and large institutions have $195K invested in Rocket Pharmaceuticals Warrant in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
21% more capital invested
Capital invested by funds: $161K → $195K (+$34K)
1.99% less ownership
Funds ownership: 1.99% → 0% (-2%)
8% less funds holding
Funds holding: 12 → 11 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$200 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$50 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$2.5K |
| 2 |
Walleye Capital
New York
|
-$1.92K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$80 |
RCKTW Hedge Fund Activity: Q3 2025 in Review
11 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q3 2025, worth a combined $195K — up 21% from $161K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RCKTW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $200. The largest seller was Walleye Trading, exiting entirely with an estimated $2.5K sold.
- 11 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q3 2025, down from 12 in Q2 2025.
- Funds reported $195K of Rocket Pharmaceuticals Warrant stock for Q3 2025, up 21% quarter-over-quarter.
- 1 fund opened new Rocket Pharmaceuticals Warrant positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest Rocket Pharmaceuticals Warrant buyer in Q3 2025 was Susquehanna International Group, an estimated $200 added.
- The largest Rocket Pharmaceuticals Warrant seller in Q3 2025 was Walleye Trading, an estimated $2.5K sold.
Based on aggregated 13F filings for Q3 2025.